Is it Rational to Continue Anti-Neoplastics with Minimal Toxicity even after Progression in Patients with no other Options? Possibly Yes

Sezer, AhmetSumbul, Ahmet TanerAbali, Huseyin2024-09-182024-09-1820141513-7368https://doi.org/10.7314/APJCP.2014.15.2.1061https://hdl.handle.net/20.500.12483/13785[Abstract Not Available]eninfo:eu-repo/semantics/openAccessIs it Rational to Continue Anti-Neoplastics with Minimal Toxicity even after Progression in Patients with no other Options? Possibly YesLetter1521061106210.7314/APJCP.2014.15.2.1061245684512-s2.0-84894646428Q3WOS:000332517500088Q3